Posted by Michael Wonder on 28 Jan 2025
Tarlatamab for previously treated patients with advanced small-cell lung cancer
28 January 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use of tarlatamab in the NHS in England.
For the time being, tarlatamab is not recommended for the treatment of adults with extensive-stage small-cell lung cancer whose cancer has progressed after two or more lines of treatment, including platinum-based chemotherapy.
